Infections caused by nightmare bacteria, a group of drug-resistant pathogens, are sharply increasing in the United States, according to a recent Centers for Disease Control and Prevention (CDC) report. These bacteria, particularly those harboring the New Delhi metallo-β-lactamase (NDM) gene, pose significant treatment challenges and represent a growing public health threat.
Rising Trends and Drug Resistance
Between 2019 and 2023, cases of carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE), commonly called nightmare bacteria, rose by nearly 70% across 29 states, impacting over one-third of the U.S. population. Within this group, infections from NDM-CRE — bacteria that produce an enzyme neutralizing last-resort antibiotics — surged by 461%. These bacteria are resistant even to newer antibiotics developed specifically to treat such infections. Only two antibiotics remain effective, and they require costly intravenous administration.
Healthcare Settings as Epicenters
Nightmare bacteria infections primarily affect hospitalized or severely ill patients, spreading mainly in healthcare environments rather than the general community. The CDC emphasizes that these infections are occurring among the “sickest-of-sick” patients, underscoring the critical need for infection control measures in hospitals and long-term care facilities. Moreover, the NDM gene can transfer between different bacterial species, accelerating the spread of resistance and complicating outbreak containment.
In 2020 alone, carbapenem-resistant Enterobacterales (CRE) caused an estimated 12,700 infections and 1,100 deaths in the U.S., highlighting the deadly potential of these pathogens. Experts warn that the sharp rise in nightmare bacteria cases limits treatment options and increases the risk of severe outcomes.
Ongoing surveillance, antibiotic stewardship, and enhanced infection prevention strategies are essential to curb the spread of these dangerous bacteria. Public health officials continue to monitor the situation closely to mitigate this emerging threat.